| dc.contributor.author | Kaya, Eda | |
| dc.contributor.author | Yılmaz, Yusuf | |
| dc.date.accessioned | 2024-03-28T07:23:23Z | |
| dc.date.available | 2024-03-28T07:23:23Z | |
| dc.date.issued | 2024 | en_US |
| dc.identifier.citation | Kaya, E., & Yilmaz, Y. (2024). Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: results from a single-center biopsy study. Chinese medical journal, 137(5), 616–618. https://doi.org/10.1097/CM9.0000000000003023 | en_US |
| dc.identifier.citation | 10.1097/CM9.0000000000003023 | en_US |
| dc.identifier.issn | 0366-6999 | |
| dc.identifier.uri | https://doi.org/10.1097/CM9.0000000000003023 | |
| dc.identifier.uri | https://hdl.handle.net/11436/8881 | |
| dc.description.abstract | To the Editor: The nomenclature for steatotic liver disease has been a topic of debate since 2020. The conventional expression, non-alcoholic fatty liver disease (NAFLD), was introduced in 1980 to describe the occurrence of steatosis in the absence of other hepatic diseases. However, in recent years, there has been a growing movement to phase out and retire this term. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Wolters Kluwer Medknow Publications | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: Results from a single-center biopsy study | en_US |
| dc.type | article | en_US |
| dc.contributor.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.contributor.institutionauthor | Yılmaz, Yusuf | |
| dc.identifier.volume | 137 | en_US |
| dc.identifier.issue | 5 | en_US |
| dc.identifier.startpage | 616 | en_US |
| dc.identifier.endpage | 618 | en_US |
| dc.relation.journal | Chinese Medical Journal | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
